Bonesupport Holding AB (publ) (LON:0RQO)

Market Cap	1.56B
Revenue (ttm)	81.55M
Net Income (ttm)	11.36M
Shares Out	n/a
EPS (ttm)	0.17
PE Ratio	136.93
Forward PE	66.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,352
Average Volume	13,359
Open	299.60
Previous Close	300.00
Day's Range	299.60 - 306.80
52-Week Range	245.00 - 404.40
Beta	0.60
RSI	43.73
Earnings Date	Oct 23, 2025

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1999
• Employees: 139
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RQO

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.

Financial numbers in SEK